Tag: COVID-19

Visby Medical adds $35m to Series E round for PCR diagnostic technology

businessnewstoday- July 2, 2022

Visby Medical, an American medical diagnostic company, has raised an additional $35 million for its PCR diagnostic technology to take its Series E funding round ... Read More

TCS roped in by QIAGEN to drive cloud transformation journey

businessnewstoday- June 16, 2022

Tata Consultancy Services (TCS) has been roped in by QIAGEN, a Germany-based provider of sample to insights solutions in life sciences and molecular diagnostics, for ... Read More

Infosys roped in by Backcountry to create and secure digital experience

businessnewstoday- May 23, 2022

Infosys has been roped in by Backcountry, an American online retailer of outdoor gear and apparel, to help in delivering a seamless and secure digital ... Read More

AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

- May 18, 2022

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19

- April 5, 2022

Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

- March 18, 2022

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

- March 18, 2022

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

US NIH stops ACTIV-2 phase 3 trial of Covid-19 drug candidate SAB-185

- March 6, 2022

SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial of the company’s SAB-185 for the treatment ... Read More

Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine

- February 27, 2022

Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

businessnewstoday- February 20, 2022

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More